Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents

MLA

Gaspari, Ana P. S., et al. “Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2’-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.” Anti-Cancer Agents in Medicinal Chemistry, vol. 21, no. 12, Aug. 2021, pp. 1602–11. EBSCOhost, https://doi.org/10.2174/0929867327666201020155105.

APA

Gaspari, A. P. S., Silva, R. S. da, Carneiro, Z. A., Carvalho, M. R. de, Carvalho, I., Pernomian, L., Ferreira, L. P., Ramos, L. C. B., Souza, G. A. de, & Formiga, A. L. B. (2021). Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2’-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry, 21(12), 1602–1611. https://doi.org/10.2174/0929867327666201020155105

Chicago

Gaspari, Ana P.S., Roberto S. da Silva, Zumira A. Carneiro, Marcelo Rodrigues de Carvalho, Ivone Carvalho, Laena Pernomian, Lucimara P. Ferreira, Loyanne C.B. Ramos, Gabriel Aguiar de Souza, and André L.B. Formiga. 2021. “Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2’-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.” Anti-Cancer Agents in Medicinal Chemistry 21 (12): 1602–11. doi:10.2174/0929867327666201020155105.